Noxopharm reports anti-cancer effects of Veyonda

Sydney anti-cancer treatment company Noxopharm (ASX: NOX) has reported anti-cancer effects of its Veyonda treatment in a small group of patients suffering advanced prostate cancer. The 14 patients’ cancers were metastatic and they had exhausted all treatment options when given Veyonda in association with low-dosage radiation in a single lesion. After six months, cancer progression…

LBT Innovations makes its first instrument sale in the EU

Medical technology and equipment developer LBT Innovations (ASX: LBT) has made its first European sale of its APAS Independence laboratory instrument (pictured). The sale was made to one of the largest clinical laboratories in the EU, Labor Dr Wisplinghoff, which employes more than 40 medical specialists. Laboratory director Professor Hilmar Wilplinghoff joined LBT Innovations CEO…

The future of nanotechnology in medicine – infographic

Around the world, researchers are increasingly thinking smaller to solve some of the biggest problems in medicine. Though most biological processes happen at the nano level, it wasn’t until recently that new technological advancements helped in opening up the possibility of nanomedicine to healthcare researchers and professionals. Today’s infographic, which comes to us from Best…

Admedus sells cardio business for $36 million

Cardiovascular device manufacturer Admedus (ASX: AHZ) has sold the distribution rights to its CardioCel and VascuCel product range for $A36.2 million to LeMaitre Vascular Inc. The company, whose ADAPT engineering process produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications, will receive $22.8 million in an upfront payment. the remainder will flow…

Cortical Dynamics may sell in South Korea

Cortical Dynamics has received regulatory approval which will lead on to an ability to sell its brain anaesthetic response monitoring (BARM) system device in South Korea. The Perth company’s Korean distributor, Globaluck, received a certificate of approval from the Korea Good Manufacturing Practice, according to an announcement by Cortical shareholder, bphenergy (ASX: BPH). The approval…